Broker Research
June 04, 2025 / 16:08 IST
Reported Consolidated quarterly numbers for ANG Lifesciences India are:Net Sales at Rs 16.82 crore in March 2025 down 55.54% from Rs. 37.84 crore in March 2024.
Story continues below Advertisement
Quarterly Net Loss at Rs. 2.06 crore in March 2025 up 43.5% from Rs. 3.65 crore in March 2024.
EBITDA stands negative at Rs. 0.05 crore in March 2025 down 101.41% from Rs. 3.55 crore in March 2024.
ANG Lifescience shares closed at 28.42 on June 03, 2025 (BSE) and has given -40.77% returns over the last 6 months and -45.46% over the last 12 months.
| ANG Lifesciences India | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Mar'25 | Dec'24 | Mar'24 | | Net Sales/Income from operations | 16.82 | 24.73 | 37.84 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 16.82 | 24.73 | 37.84 | | EXPENDITURE | | Consumption of Raw Materials | 10.63 | 16.90 | 33.06 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -0.18 | -0.85 | -7.99 | | Power & Fuel | -- | -- | -- | | Employees Cost | 4.17 | 4.44 | 4.15 | | Depreciation | 1.42 | 1.96 | 2.05 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 2.90 | 6.38 | 5.27 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -2.12 | -4.11 | 1.31 | | Other Income | 0.65 | -0.27 | 0.19 | | P/L Before Int., Excpt. Items & Tax | -1.47 | -4.38 | 1.50 | | Interest | 2.42 | 2.00 | 3.84 | | P/L Before Exceptional Items & Tax | -3.89 | -6.38 | -2.34 | | Exceptional Items | -- | -- | -1.74 | | P/L Before Tax | -3.89 | -6.38 | -4.08 | | Tax | -1.83 | -1.19 | -0.43 | | P/L After Tax from Ordinary Activities | -2.06 | -5.19 | -3.65 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -2.06 | -5.19 | -3.65 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | -2.06 | -5.19 | -3.65 | | Equity Share Capital | 13.06 | 13.06 | 13.06 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -1.56 | -3.98 | -2.75 | | Diluted EPS | -1.56 | -3.98 | -2.75 | | EPS After Extra Ordinary | | Basic EPS | -1.56 | -3.98 | -2.75 | | Diluted EPS | -1.56 | -3.98 | -2.75 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
